Cambridge Raman Imaging Ltd. (CRIL), was registered in the UK in 2018. Our focus is on bringing to market high speed, label-free Raman imaging instruments. Our first application is in medical imaging, delivering better patient outcomes through faster and more accurate tumour diagnosis and treatment.
The company is supported by co-founder Frontier IP Group Plc. a company dedicated to the commercialisation of new technology. Frontier IP provides ‘hands-on’ leadership to support CRIL as well as developing the business strategy and raising funding. Together the founders have built a team of dedicated scientists forming an extensive knowledge base in the field of ultra-fast lasers, Coherent Raman Spectroscopy and imaging.
CRIL has formed a subsidiary in Italy in the Milan area and is raising funding to cover the cost of building a working prototype CRS microscope for medical imaging.
Our focus is on bringing to market better patient outcomes through faster and more accurate tumour diagnosis and treatment.